Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis

Prostate cancer epidemiology in the United States

(2012) Otis W. Brawley   WORLD JOURNAL OF UROLOGY

Runx2/Smad3 Complex Negatively Regulates TGF-β-Induced Connective Tissue Growth Factor gene Expression in Vascular Smooth Muscle Cells

(2011) Yoshiaki Ohyama et al.   Journal of Atherosclerosis and Thrombosis

PC3 is a cell line characteristic of prostatic small cell carcinoma

(2011) Sheng Tai et al.   PROSTATE

Galectin-9 induces osteoblast differentiation through the CD44/Smad signaling pathway

(2010) Rena Tanikawa et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

BMP2-activated Erk/MAP Kinase Stabilizes Runx2 by Increasing p300 Levels and Histone Acetyltransferase Activity

(2010) Ji Hae Jun et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Regulation of Sealing Ring Formation by L-plastin and Cortactin in Osteoclasts

(2010) Tao Ma et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Regulation of Erk1/2 activation by osteopontin in PC3 human prostate cancer cells

(2010) Brian W Robertson et al.   Molecular Cancer

Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature

(2009) George J. Klarmann et al.   CLINICAL & EXPERIMENTAL METASTASIS

Suppression of Androgen-Independent Prostate Cancer Cell Aggressiveness by FTY720: Validating Runx2 as a Potential Antimetastatic Drug Screening Platform

(2009) C.-W. Chua et al.   CLINICAL CANCER RESEARCH

Osteopontin induces β-catenin signaling through activation of Akt in prostate cancer cells

(2009) Brian W. Robertson et al.   EXPERIMENTAL CELL RESEARCH

Identification and characterization of Runx2 phosphorylation sites involved in matrix metalloproteinase-13 promoter activation

(2009) Nagarajan Selvamurugan et al.   FEBS LETTERS

Characterization of the expression of variant and standard CD44 in prostate cancer cells: Identification of the possible molecular mechanism of CD44/MMP9 complex formation on the cell surface

(2009) B. Desai et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Repression of Runx2 by Androgen Receptor (AR) in Osteoblasts and Prostate Cancer Cells: AR Binds Runx2 and Abrogates Its Recruitment to DNA

(2009) Sanjeev K. Baniwal et al.   MOLECULAR ENDOCRINOLOGY

Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions

(2009) J Akech et al.   ONCOGENE

Heat Shock Co-Activates Interleukin-8 Transcription

(2008) Ishwar S. Singh et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Expression and activity of Runx2 mediated by hyaluronan during chondrocyte differentiation

(2008) Y. Tanne et al.   ARCHIVES OF ORAL BIOLOGY

CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis

(2008) E M Hurt et al.   BRITISH JOURNAL OF CANCER

Runx2 Transcriptional Activation of Indian Hedgehog and a Downstream Bone Metastatic Pathway in Breast Cancer Cells

(2008) J. Pratap et al.   CANCER RESEARCH

Specific Residues of RUNX2 Are Obligatory for Formation of BMP2-Induced RUNX2-SMAD Complex to Promote Osteoblast Differentiation

(2008) Amjad Javed et al.   CELLS TISSUES ORGANS

Modulation of mouse RANKL gene expression by Runx2 and vitamin D3

(2008) Riko Kitazawa et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis

(2008) R. E. Miller et al.   MOLECULAR CANCER THERAPEUTICS

Tumor cell cycle arrest induced by shear stress: Roles of integrins and Smad

(2008) S.-F. Chang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA